2012 annual financial data
Aurinia Pharmaceuticals 2012 Operating margin
Direct answer
Operating margin was -88.8%.
Operating income was -5,468,270.96 USD and net income was -9,737,342.06 USD.
Operating cash flow was -6,546,847.2 USD.
Get free Aurinia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,157,836 USD
- Operating income
- -5,468,270.96 USD
- Net income
- -9,737,342.06 USD
- Operating cash flow
- -6,546,847.2 USD